Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Low testosterone might be a common cause of hair loss in male dogs.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Finasteride helps prevent kidney stones, but side effects need more research.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Secretome-based therapies could improve hair growth better than current treatments.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Testosterone changes reduce thyroxin levels in rats.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone increases hair testosterone levels, stress raises hair cortisol, and relationship status affects hormone levels.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.